Fentanyl, xylazine, and bromazolam: Urine toxicology trends in a San Francisco safety net opioid treatment patient cohort 2023-2025.

Saved in:
Bibliographic Details
Title: Fentanyl, xylazine, and bromazolam: Urine toxicology trends in a San Francisco safety net opioid treatment patient cohort 2023-2025.
Authors: Halifax JC; Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA. Electronic address: john_halifax@berkeley.edu., Lim L; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA., Ahern J; Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA., Steiger S; Department of Psychiatry and Behavioral Sciences and Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Medicine, University of California San Francisco, San Francisco, CA, USA., Shapiro BJ; Department of Psychiatry and Behavioral Sciences and Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA., Lynch KL; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA; Clinical Laboratory of San Francisco General Hospital and Trauma Center, San Francisco Department of Public Health, San Francisco, CA, USA.
Source: Drug and alcohol dependence [Drug Alcohol Depend] 2026 Jul 01; Vol. 284, pp. 113185. Date of Electronic Publication: 2026 May 01.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Ireland NLM ID: 7513587 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0046 (Electronic) Linking ISSN: 03768716 NLM ISO Abbreviation: Drug Alcohol Depend Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0046
DOI:10.1016/j.drugalcdep.2026.113185